Accelerated Phase CML, BCR-ABL1 Positive

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Biospecimen CollectionN/A1 trial
Active Trials
NCT04666025CompletedEst. May 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
City TherapeuticsBiospecimen Collection

Clinical Trials (1)

NCT04666025City TherapeuticsBiospecimen Collection

SARS-CoV-2 Donor-Recipient Immunity Transfer

Start: Sep 2020Est. completion: May 2023
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space